Hyderabad: The country’s first potential COVID-19 vaccine has received the green light from Drug Controller General of India (DCGI) for Phase I and II human clinical trials.
The trials will begin across the country in July.
The vaccine, COVAXIN, has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council for Medical Research (ICMR). It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus.
The vaccine has shown promising results in preclinical studies, demonstrating extensive safety and effective immune responses.
Globally, AstraZeneca’s vaccine followed by Moderna’s are in the lead with the latter scheduled to conduct Phase III trials from mid-July.
AstraZeneca, which has developed the vaccine with the help of researchers at the University of Oxford, has started large-scale mid-stage human trials.
China too has developed a vaccine in association with CanSino Biologics, which shows promising results in early clinical trials.
Mumbai: The Ranbir Kapoor starrer ‘Animal’ might have left cash registers ringing at the box…
Lucknow: A project to build a ropeway along the trek to Vaishno Devi temple will…
Bhubaneswar: The Enforcement Directorate (ED) has seized unaccounted cash amounting to Rs.1.39 crore during raids…
Bhubaneswar: The leaders of all three major parties in Odisha - BJP, BJD and Congress…
Kolkata: CV Ananda Bose has been involved in multiple controversies and had several run-ins with…
Bhubaneswar: The Nandankanan Zoological Park (NZP) near Bhubaneswar has received 11 species of animals and…
Mumbai: Abhishek Bachchan’s performance in Shoojit Sircar’s ‘I Want To Talk’ is being lauded by…
New Delhi: The Supreme Court on Monday dismissed pleas challenging the 42nd Amendment to the…